262 related articles for article (PubMed ID: 15618061)
21. ApoB-100 and ApoB/ApoA-1 ratio in children and adolescents from families with very early myocardial infarction.
Dirisamer A; Stadler A; Bucek RA; Widhalm K
Acta Paediatr; 2006 Jul; 95(7):810-3. PubMed ID: 16801176
[TBL] [Abstract][Full Text] [Related]
22. ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects.
Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Walldius G; Hamsten A; Hellénius ML; Fisher RM
Eur Heart J; 2007 Nov; 28(21):2637-43. PubMed ID: 17766927
[TBL] [Abstract][Full Text] [Related]
23. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
Meisinger C; Döring A; Löwel H;
Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
[TBL] [Abstract][Full Text] [Related]
24. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Thorand B; Baumert J; Kolb H; Meisinger C; Chambless L; Koenig W; Herder C
Diabetes Care; 2007 Apr; 30(4):854-60. PubMed ID: 17392546
[TBL] [Abstract][Full Text] [Related]
25. Gender-Specific short and long-term mortality in diabetic versus nondiabetic patients with incident acute myocardial infarction in the reperfusion era (the MONICA/KORA Myocardial Infarction Registry).
Meisinger C; Heier M; von Scheidt W; Kirchberger I; Hörmann A; Kuch B
Am J Cardiol; 2010 Dec; 106(12):1680-4. PubMed ID: 21126609
[TBL] [Abstract][Full Text] [Related]
26. Living alone is associated with an increased risk of type 2 diabetes mellitus in men but not women from the general population: the MONICA/KORA Augsburg Cohort Study.
Meisinger C; Kandler U; Ladwig KH
Psychosom Med; 2009 Sep; 71(7):784-8. PubMed ID: 19592514
[TBL] [Abstract][Full Text] [Related]
27. [Psychosocial factors as risk for coronary heart disease--status with special reference to the KORA platform].
Ladwig KH; Marten-Mittag B; Baumert J;
Gesundheitswesen; 2005 Aug; 67 Suppl 1():S86-93. PubMed ID: 16032523
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease.
Schlitt A; Blankenberg S; Bickel C; Meyer J; Hafner G; Jiang XC; Rupprecht HJ
Int J Cardiol; 2005 Jul; 102(3):477-85. PubMed ID: 16004894
[TBL] [Abstract][Full Text] [Related]
29. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
[TBL] [Abstract][Full Text] [Related]
30. Do apolipoproteins improve coronary risk prediction in subjects with metabolic syndrome? Insights from the North Italian Brianza cohort study.
Gianfagna F; Veronesi G; Guasti L; Chambless LE; Brambilla P; Corrao G; Mancia G; Cesana G; Ferrario MM
Atherosclerosis; 2014 Sep; 236(1):175-81. PubMed ID: 25062081
[TBL] [Abstract][Full Text] [Related]
31. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.
Walldius G; Jungner I
J Intern Med; 2006 May; 259(5):493-519. PubMed ID: 16629855
[TBL] [Abstract][Full Text] [Related]
32. Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease.
Sniderman AD; Holme I; Aastveit A; Furberg C; Walldius G; Jungner I
Am J Cardiol; 2007 Jul; 100(2):217-21. PubMed ID: 17631073
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein B/apolipoprotein A-I ratio and apolipoprotein B: long-term predictors of myocardial infarction in initially healthy middle-aged men--a 13-year follow-up.
Schmidt C; Bergström G
Angiology; 2014 Nov; 65(10):901-5. PubMed ID: 24277914
[TBL] [Abstract][Full Text] [Related]
34. Increased apoB/apoA-I ratio is predictive of peripheral arterial disease in initially healthy 58-year-old men during 8.9 years of follow-up.
Johansson L; Schmidt C
Angiology; 2009; 60(5):539-45. PubMed ID: 19022789
[TBL] [Abstract][Full Text] [Related]
35. Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study.
Oksala N; Seppälä I; Hernesniemi J; Lyytikäinen LP; Kähönen M; Mäkelä KM; Reunanen A; Jula A; Ala-Korpela M; Lehtimäki T
Ann Med; 2013 Mar; 45(2):141-8. PubMed ID: 22524251
[TBL] [Abstract][Full Text] [Related]
36. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study.
Holme I; Høstmark AT; Anderssen SA
J Intern Med; 2007 Aug; 262(2):235-43. PubMed ID: 17645591
[TBL] [Abstract][Full Text] [Related]
37. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
[TBL] [Abstract][Full Text] [Related]
38. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I.
Iso H; Kobayashi M; Ishihara J; Sasaki S; Okada K; Kita Y; Kokubo Y; Tsugane S;
Circulation; 2006 Jan; 113(2):195-202. PubMed ID: 16401768
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke.
Walldius G; Jungner I
Curr Opin Cardiol; 2007 Jul; 22(4):359-67. PubMed ID: 17556890
[TBL] [Abstract][Full Text] [Related]
40. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
